Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Puma Biotechnology (PBYI) Return on Sales (2017 - 2025)

Puma Biotechnology (PBYI) has disclosed Return on Sales for 9 consecutive years, with 0.22% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 1.0% year-over-year to 0.22%, compared with a TTM value of 0.15% through Dec 2025, up 5.0%, and an annual FY2024 reading of 0.1%, up 11.0% over the prior year.
  • Return on Sales was 0.22% for Q4 2025 at Puma Biotechnology, up from 0.17% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.25% in Q3 2024 and bottomed at 0.97% in Q3 2021.
  • Average Return on Sales over 5 years is 0.01%, with a median of 0.07% recorded in 2021.
  • The sharpest move saw Return on Sales plummeted -66bps in 2021, then surged 96bps in 2022.
  • Year by year, Return on Sales stood at 0.07% in 2021, then rose by 11bps to 0.08% in 2022, then plummeted by -274bps to 0.14% in 2023, then surged by 251bps to 0.22% in 2024, then grew by 3bps to 0.22% in 2025.
  • Business Quant data shows Return on Sales for PBYI at 0.22% in Q4 2025, 0.17% in Q3 2025, and 0.12% in Q2 2025.